Literature DB >> 12053056

Serum levels of soluble CD26 and CD30 in patients on hemodialysis.

Kazushi Nakao1, Yoshio Nagake, Akira Okamoto, Haruo Ichikawa, Masahiro Yamamura, Hirofumi Makino.   

Abstract

BACKGROUND/AIMS: Various abnormalities of the immune system have been demonstrated in patients on hemodialysis (HD). We hypothesize that the imbalance between type 1 helper T (Th1) cells and type 2 helper T (Th2) cells in patients on HD contributes to these abnormalities. Furthermore, we investigate the relationship between the Th1/Th2 imbalance and HD duration.
METHODS: We measured the serum levels of soluble CD26 (sCD26) and soluble CD30 (sCD30) in 47 patients on HD and in 13 patients with chronic renal failure not on HD and analyzed the effect of HD duration on the serum levels of sCD26 and sCD30.
RESULTS: The serum level of sCD26 in the HD group was significantly lower than that in the control group. On the other hand, the serum levels of sCD30 in the HD group and in the CRF group were significantly higher than in the control group. In the short-term HD group (<1 year), the serum levels of sCD26 were lower and the sCD30 levels higher than those in middle-term HD group (1-10 years).
CONCLUSIONS: In the HD group, the Th1/Th2 balance may shift towards Th2 dominance. It is possible that this imbalance contributes to the abnormality of the immune system in HD patients. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12053056     DOI: 10.1159/000058395

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  7 in total

1.  Pre-transplant and post-transplant soluble CD30 for prediction and diagnosis of acute kidney allograft rejection.

Authors:  Mohsen Nafar; Farhat Farrokhi; Mohammad Vaezi; Amir-Ebrahim Entezari; Fatemeh Pour-Reza-Gholi; Ahmad Firoozan; Behzad Eniollahi
Journal:  Int Urol Nephrol       Date:  2008-12-30       Impact factor: 2.370

2.  Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid, likely triggered by scabies, in a hemodialysis patient with human leukocyte antigen-DQB1*03:01.

Authors:  Arata Hibi; Yuto Kasahara; Yoshitaka Ishihara; Koichi Hata; Norihisa Hosokawa; Takahiko Nakagawa
Journal:  CEN Case Rep       Date:  2020-01-28

3.  CD26 expression on CD4+T cells in patients with cutaneous leishmaniasis.

Authors:  R Jafari-Shakib; S Ajdary; Z Mohtasham Amiri; A M Mohammadi; K Nourijelyani; H Mortazavi; M A Shokrgozar; B Nikbin; A Khamesipour
Journal:  Clin Exp Immunol       Date:  2008-05-05       Impact factor: 4.330

4.  BK Virus Load Associated with Serum Levels of sCD30 in Renal Transplant Recipients.

Authors:  Haidar A Shamran; Salma N Malik; Jinan M Al-Saffer; Rana S Jawad
Journal:  Int J Microbiol       Date:  2016-03-09

Review 5.  Immunologic monitoring in kidney transplant recipients.

Authors:  Natavudh Townamchai; Kassem Safa; Anil Chandraker
Journal:  Kidney Res Clin Pract       Date:  2013-05-29

6.  Immunological Alterations due to Hemodialysis Might Interfere with Early Complications in Renal Transplantation.

Authors:  Kristin Mai; Andreas Boldt; Hans-Michael Hau; Michael Kirschfink; Stephan Schiekofer; Frieder Keller; Joachim Beige; Athanassios Giannis; Ulrich Sack; Franz Maximilian Rasche
Journal:  Anal Cell Pathol (Amst)       Date:  2019-03-25       Impact factor: 2.916

7.  Serum Levels of Soluble CD26, A Novel Prognostic Marker for Hepatitis E Infection.

Authors:  Alireza Rafiei; Abolghasem Ajami; Araz Mohammad Mirabi; Mohammad Jafar Saffar; Omolbanin Amjadi; Mohammad Reza Haghshenas; Farshideh Abedian; Pouya Khaje-Enayati
Journal:  Jundishapur J Microbiol       Date:  2016-02-15       Impact factor: 0.747

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.